Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pathogenesis of Acute-on-Chronic Liver Failure and Mechanisms of Plasma Exchange with Human Serum Albumin 5%
2017-002677-19Phase 3Terminated
- Sponsor
- Instituto Grifols
- Start
- Feb 2019
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3 trial of albumin (human) in acute-on-chronic liver failure (ACLF), Cirrhosis and chronic inflammation, sponsored by Instituto Grifols. Started Feb 2019; status: terminated.
02
Drugs
albumin (human)
03
Conditions
acute-on-chronic liver failure (ACLF)Cirrhosischronic inflammation
Beyond the preview
Go deeper on 2017-002677-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-002677-19.